These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Jain PK; McNaught CE; Anderson AD; MacFie J; Mitchell CJ Clin Nutr; 2004 Aug; 23(4):467-75. PubMed ID: 15297081 [TBL] [Abstract][Full Text] [Related]
3. Probiotic/synbiotic therapy for treating critically ill patients from a gut microbiota perspective. Shimizu K; Ogura H; Asahara T; Nomoto K; Morotomi M; Tasaki O; Matsushima A; Kuwagata Y; Shimazu T; Sugimoto H Dig Dis Sci; 2013 Jan; 58(1):23-32. PubMed ID: 22903218 [TBL] [Abstract][Full Text] [Related]
4. Probiotics in critically ill children. Singhi SC; Kumar S F1000Res; 2016; 5():. PubMed ID: 27081478 [TBL] [Abstract][Full Text] [Related]
5. Recurrent bacterial translocation from gut and sepsis in Head and neck cancer patients and its prevention by probiotics. Gunduz M; Murakami D; Gunduz I; Tamagawa S; Hiraoka M; Sugita G; Hotomi M Med Hypotheses; 2018 Nov; 120():124-127. PubMed ID: 30220331 [TBL] [Abstract][Full Text] [Related]
6. Immunology and probiotic impact of the newborn and young children intestinal microflora. Bezirtzoglou E; Stavropoulou E Anaerobe; 2011 Dec; 17(6):369-74. PubMed ID: 21515397 [TBL] [Abstract][Full Text] [Related]
7. Probiotic, prebiotic, and synbiotic use in critically ill patients. Morrow LE; Gogineni V; Malesker MA Curr Opin Crit Care; 2012 Apr; 18(2):186-91. PubMed ID: 22343306 [TBL] [Abstract][Full Text] [Related]
8. Probiotics and irritable bowel syndrome: rationale and clinical evidence for their use. Barbara G; Stanghellini V; Cremon C; De Giorgio R; Gargano L; Cogliandro R; Pallotti F; Corinaldesi R J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 2():S214-7. PubMed ID: 18685517 [TBL] [Abstract][Full Text] [Related]
9. Probiotic bacteria prevent hepatic damage and maintain colonic barrier function in a mouse model of sepsis. Ewaschuk J; Endersby R; Thiel D; Diaz H; Backer J; Ma M; Churchill T; Madsen K Hepatology; 2007 Sep; 46(3):841-50. PubMed ID: 17659579 [TBL] [Abstract][Full Text] [Related]
10. Probiotic use in the critically ill. Singhi SC; Baranwal A Indian J Pediatr; 2008 Jun; 75(6):621-7. PubMed ID: 18759092 [TBL] [Abstract][Full Text] [Related]
11. Probiotic and synbiotic therapy in the critically ill: State of the art. Davison JM; Wischmeyer PE Nutrition; 2019 Mar; 59():29-36. PubMed ID: 30415160 [TBL] [Abstract][Full Text] [Related]
12. Synbiotics and probiotics in the critically ill after the PROPATRIA trial. Morrow LE; Gogineni V; Malesker MA Curr Opin Clin Nutr Metab Care; 2012 Mar; 15(2):147-50. PubMed ID: 22248590 [TBL] [Abstract][Full Text] [Related]
13. Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Alberda C; Gramlich L; Meddings J; Field C; McCargar L; Kutsogiannis D; Fedorak R; Madsen K Am J Clin Nutr; 2007 Mar; 85(3):816-23. PubMed ID: 17344505 [TBL] [Abstract][Full Text] [Related]
14. Probiotics in the intensive care unit. Morrow LE; Gogineni V; Malesker MA Nutr Clin Pract; 2012 Apr; 27(2):235-41. PubMed ID: 22473797 [TBL] [Abstract][Full Text] [Related]
15. In vitro screening of probiotic lactic acid bacteria and prebiotic glucooligosaccharides to select effective synbiotics. Grimoud J; Durand H; Courtin C; Monsan P; Ouarné F; Theodorou V; Roques C Anaerobe; 2010 Oct; 16(5):493-500. PubMed ID: 20670686 [TBL] [Abstract][Full Text] [Related]
16. Controversies in the management of the critically ill: the role of probiotics. Theodorakopoulou M; Perros E; Giamarellos-Bourboulis EJ; Dimopoulos G Int J Antimicrob Agents; 2013 Jun; 42 Suppl():S41-4. PubMed ID: 23664676 [TBL] [Abstract][Full Text] [Related]